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Abstract: Hyperglycemia was induced in 20 male, white, New Zealand rabbits (2-3 kg) (Oryctolagus cuniculus huxley) by alloxan
(100 mg/kg body weight, I.V.) and maintained for 16 weeks without insulin treatment. Blood samples were taken from both diabetic
and non-diabetic rabbits at the same time for measurement of plasma enzymes. Levels of glutamic oxalacetic transaminase (GOT)
and lactate dehydrogenase (LDH) were determined after treatment. The levels of LDH and GOT were 155.6 ± 41.9 U/L and 47.0
± 20.4 U/L in the control group respectively. These parameters were 286.9 ± 142.9 U/L and 93.9 ± 62.5 U/L in the diabetic group
respectively. It was observed that LDH (p < 0.05) was significantly increased, whereas GOT was not significantly increased (p >
0.05) in the diabetic group. In conclusion, we agree that routine use of LDH measurement to monitor diabetic status may be useful,
but the characteristic parameters of diabetes mellitus are better indicators.
Key Words: Diabetes mellitus, LDH, GOT, Rabbit

Tavflanlarda Deneysel Diyabetin Plazma Laktat Dehidrogenaz ve Glutamik Oksalasetik
Transaminaz Enzim Düzeylerine Etkisi
Özet: Bu çal›flmada, diabet 20 erkek, beyaz, Yeni Zelanda ›rk› tavflan (Oryctolagus cuniculus huxley) alloxan verilerek (100 mg/kg
vucut i.v.) oluflturuldu ve insulin tedavisi yap›lmaks›z›n 16 hafta bekletildi. Plazma enzimlerini ölçümü için kan örnekleri hem diabetik
hemde kontrol grublar›ndan al›nd›. Muameleden sonra laktat dehidrogenaz (LDH) ve glutamik oksalasetik transaminaz (GOT)
seviyeleri belirlendi. LDH ve GOT seviyeleri s›ras›yla, kontrol grubunda 155,6 ± 41,9 U/L ve 47,0 ± 20,4 U/L iken, diabetli grubunda
286,9 ± 142,9 U/L ve 93,9 ± 62,5 U/L idi. Yap›lan istatistiki analiz sonucu, diabetli, plazma LDH de¤erinin önemli oranda (p < 0,05)
yükseldi¤i ancak GOT yüksekli¤inin önemsiz oldu¤u (p > 0,05) görüldü. Sonuç olarak, LDH diabetes mellitus için bir indikatör
olabilirler ancak, diabetes mellitus’un mevcut karakteristik paremetreleri daha iyi birer indikatördürler.
Anahtar Sözcükler: Diabetes mellitus, LDH, GOT, Tavflan

Introduction
Diabetes mellitus is known in dogs, cats, rats and
mice and probably occurs in most mammals, although it
is only likely to be diagnosed in laboratory animals (1).
The disease is accepted to be the commonest endocrine
disease, which are multi-systemic disorders resulting
from deficiency in the secretion or action of the
pancreatic hormone insulin, which in turn produces
profound abnormalities of metabolism (2). On the basis
of a case history, the clinical and paraclinical
manifestation of diabetes mellitus are reviewed.

Since muscle and liver dysfunction is frequently
associated with diabetes mellitus, many clinical reports
have indicated that serum enzyme activities derived from
the muscle and liver such as creatine phosphokinase
(CPK), LDH and GOT are elevated.
The levels of enzyme increased in diabetes mellitus is
a metabolic result already treatable with pancreas
hormones. Before the availability of sensitive pancreas
hormone analysis, increased serum or plasma enzyme
levels were considered important evidence supporting the
diagnosis of diabetes mellitus (1).
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In widespread enzyme screening programs, although
a number of studies have been carried out in patients
with hyperglycemia comparing serum enzyme levels (321), the results are mostly conflicting.
In spite of the reason explained above, there is still
great contradiction between results. Therefore, the
purpose of this study was to assess the predictive value of
LDH and GOT in discriminating between rabbits with
experimental diabetes mellitus and control rabbits.

Analysis of Data: All data were expressed as mean ±
standard deviation (SD). For statistical analysis the
SPSS/PC+ package (SPSS/PC+, Chicago, IL, USA) was
used. For all parameters, means and SE were calculated
according to the standard methods. The Mann-Whitney U
test was used to test for differences between means of
the treatments and the control rabbits. The significance
level was p = 0.05 for all tests.

Result
Materials and Methods
Subjects: Twenty male New Zealand rabbits (2-3 kg
in weight) from the serum animal farm were used. The
animals were fed a diet of rabbit pellets and water ad
libitum.
Induction of experimental diabetes in rabbits:
Hyperglycemia was produced by iv administration of
alloxan (100 mg/kg body weight) in 16 h fasting rabbits.
After 72 h of alloxan administration, fasting blood
glucose was measured. The rabbits were not treated with
insulin and the animals with fasting blood glucose ≥ 250
mg/dl were considered diabetic. Four months after
administration of alloxan monohydrate, blood samples
were obtained from a cardiac puncture for the
determination of plasma glucose, LDH and GOT. Five
milliliters of blood were drawn immediately into icechilled siliconized disposable glass tubes contained EDTA
(1 mg/ml). The plasma samples were obtained by
centrifuging blood samples at 3000 rpm for 30 minutes
at 4 °C. The measurement of enzymes and glucose levels
was carried out in these plasma samples.
Measurement of Enzyme: Plasma enzyme levels
were measured by autoanalyzer (Hitachi 705, Japan)
using commercial kits.

Table 1.

Physical and physiological characteristics of the rabbits
(Mean ± SD).
Control
_
X ± x-

Diabetic
_
X ± x-

P

10

10

--

Body weight (g)

2425 ± 125

2385 ± 113

ns

Plasma glucose (mg/dl)

89.6 ± 7.4

404 ± 79.3

< 0.001

N

ns: not significant
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The body weights and plasma glucose
concentrations of each group are shown in Table 1. and
Figure 1. Hyperglycemia in experimental group
confirmed by blood glucose concentration (BGC) was
significantly higher than that in the control group (p <
0.001). The body weights of each group did not change
significantly during the study.
LDH and GOT data are given in Table 2. and Figure 2.
An increase in LDH was observed in the diabetic group,
but GOT was slightly higher in the diabetic group than in
the control group.

Discussion
This study showed that glucose and LDH were
significantly higher. As for GOT, no significant differences
existed between the levels in rabbits with diabetes
mellitus compared with control rabbits. Correlation
analysis showed that LDH is correlated with BGC.
According to these results, it may be speculated that LDH
provides additional information about diabetes mellitus.
We also found that high BGC, a multi-systemic disorder
resulting from deficiency in the secretion or action of the
pancreatic hormone insulin, is a better indicator of
diabetes mellitus than plasma enzyme. These findings are

Table 2.

LDH and GOT levels (Mean ± SD).

Control
_
X ± x-

Diabetic
_
X ± x-

P

LDH U/L

155.6 ± 41.9

286.9 ± 142.0

<0.05

GOT U/L

47.0 ± 20.4

93.9 ± 62.5

ns

ns: not significant

600

500

500

400

400

300

Glucose in Control and Diabetic Rabbits.

in accordance with and in contradiction with other studies
in which the subjects were generally human.
The results of the present study indicated that plasma
LDH levels in rabbits with diabetes mellitus were
significantly higher when compared with the controls. To
date, no study examining plasma enzyme in diabetes
mellitus has been reported in rabbits. Therefore, we were
not able to compare our results with others. Although a
number of studies about LDH and GOT levels in diabetes
mellitus have been carried out, the results are mostly in
conflict. Oliver et al. (3), Tanaka et al. (9) and
Margiavichene et al. (12) did not observe any increases in
LDH between diabetes and controls; consequently their
results are not in accordance with ours. Melinkeri et al.
(5), Awaji et al. (6), Nikolaeva et al. (8), Jones et al. (10),
Cheshchevik (13), Zappacosta et al. (14) and Goldberg et
al. (20) indicated that LDH levels were higher in patients
with diabetes mellitus than those in normal subjects.
Consequently, these reports are in accordance with our
findings. On the other hand, Cai (7) and Ryder et al. (11)
observed decreases in LDH in diabetic subjects. These
results are in contradiction with our findings and those of
other studies. In addition, Fernandez et al. (15) indicated
that the level of GOT did not change in diabetes mellitus
compared with normal subjects. Consequently, their
report is in accordance with ours. Tanaka et al. (9), Jones
et al. (10), Piyachaturawat et al. (16), Nanbara et al.
(17), Rao et al. (18), Henderson et al. (19), Goldberg et
al. (20) and Awadallah and El-Dessoukey (21) indicated
that GOT levels were higher in diabetes mellitus than
those of normal subjects, but Awaji et al. (6) observed

Figure 2.
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decreases in GOT between diabetes and controls.
Consequently, their report is in contradiction with ours.
These controversial data may be due to using different
animals as study subjects or different experimental
treatment.
Even though several theories have been proposed to
explain these differences, the mechanism of enzymes are
not well understood. Some investigators have suggested
that the increase in enzymes levels in patients with
diabetes mellitus resulted from the influence of insulin on
liver and muscle tissue (2). The other possibilities include
malnutrition, hepatic anoxia and infection in diabetes
mellitus. However, the enzyme released from other
organs may contribute to the change in levels in enzyme.
Our results indicating the fact that plasma LDH levels
were significantly higher in diabetic rabbits than those in
the control group support these possibilities.
In conclusion, the present study demonstrated that
the serum enzymes levels were elevated in alloxaninduced diabetic rabbits compared with the control
values. Our results also showed that GOT did not increase
significantly in hyperglycemic animals (p > 0.05).
However, this study indicated that further experiments
should be performed to investigate what is responsible
for the elevation of enzymes in muscle and liver. This test
may be used in forensic study if more studies confirm our
findings, because of the unstability of serum enzyme.
Such a test could also be of value in population studies,
and it would be of interest to understand the molecular
basis of refractoriness of hyperglycemia.
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